Collectively, these findings suggest that elevated CXCL3 expression in liver cancer is linked to poor prognosis, immune cell recruitment, CXCR2 ligand co-expression, and activation of tumor-related immune pathways. The gene discussed is CXCR2; the disease is neoplasm.